Develops prescription digital therapeutics (PDTs), delivered through smartphone and tablet applications, that train the brain to help manage chronic conditions and pain
Develops prescription digital therapeutics (PDTs), delivered through smartphone and tablet applications, that train the brain to help manage chronic conditions and pain. Its Regulora product is available in Canada; U.S. distribution has been suspended.
The top three firms on F4's Healthcare & Digital Health investor list.